CLAG

DRUG3 trials

Sponsors

University of Cincinnati, dr hab. n. med. Agnieszka Wierzbowska, Nanfang Hospital, Southern Medical University

Conditions

AMLAcute Myeloid LeukemiaChronic Myeloid Leukemia, Blast Crisis

Phase 2

A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia

WithdrawnNCT00594555

University of CincinnatiAcute Myeloid Leukemia, Chronic Myeloid Leukemia, Blast Crisis

Start: 2007-11-30End: 2008-11-30Target: 20Updated: 2008-10-31

Phase 3

Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia

dr hab. n. med. Agnieszka WierzbowskaAcute Myeloid Leukemia

Start: 2014-02-28End: 2018-02-28Target: 400Updated: 2014-02-27

Unknown Phase

A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure

Not yet recruitingNCT05875649

Nanfang Hospital, Southern Medical UniversityAML

Start: 2023-07-02End: 2027-12-20Target: 137Updated: 2023-07-05